VSee Health, Inc. (NASDAQ:VSEE) Sees Large Decline in Short Interest

VSee Health, Inc. (NASDAQ:VSEEGet Free Report) saw a significant decline in short interest during the month of June. As of June 15th, there was short interest totaling 1,048,440 shares, a decline of 45.9% from the May 31st total of 1,936,650 shares. Based on an average daily trading volume, of 1,741,369 shares, the days-to-cover ratio is currently 0.6 days.

VSee Health Stock Up 1.7%

Shares of VSee Health stock opened at $0.11 on Tuesday. VSee Health has a one year low of $0.10 and a one year high of $2.52. The company has a market cap of $399,240.00 and a P/E ratio of -0.21. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.41 and a current ratio of 0.41. The firm has a fifty day moving average of $0.17 and a two-hundred day moving average of $0.28.

VSee Health (NASDAQ:VSEEGet Free Report) last issued its quarterly earnings results on Friday, May 15th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06. The business had revenue of $3.16 million for the quarter, compared to analyst estimates of $4.80 million. VSee Health had a negative net margin of 92.36% and a negative return on equity of 11,636.34%.

Hedge Funds Weigh In On VSee Health

A hedge fund recently bought a new position in VSee Health stock. Virtu Financial LLC bought a new position in shares of VSee Health, Inc. (NASDAQ:VSEEFree Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 66,489 shares of the company’s stock, valued at approximately $25,000. Hedge funds and other institutional investors own 1.01% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of VSee Health in a research report on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Check Out Our Latest Analysis on VSee Health

About VSee Health

(Get Free Report)

VSee Health is a telehealth technology company that develops secure, HIPAA-compliant software solutions for virtual care. The company’s flagship platform offers high-definition video visits, real-time messaging and collaboration tools designed to streamline remote consultations between patients and healthcare providers. VSee’s solutions are built to integrate with electronic health record systems and include features such as digital waiting rooms, screen sharing and file transfer capabilities.

In addition to video conferencing, VSee Health provides remote patient monitoring (RPM) tools that enable clinicians to collect biometric data, such as blood pressure, heart rate and glucose readings, from patients in their homes.

Featured Articles

Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.